Not applicableUnknownNCT05486988What this trial is testingCtDNA as a Biomarker for Treatment in Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Fuzhou General Hospital 500
Early research (Phase 1)Looking for participantsNCT05194982What this trial is testingBL-B01D1 in Patients With Locally Advanced or Metastatic Solid TumorWho this might be right forLocally Advanced or Metastatic Solid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 570
Early research (Phase 1)Looking for participantsNCT07613723What this trial is testingTest the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid MalignanciesWho this might be right forOvarian CancerSquamous Non-Small Cell Lung Cancer (NSCLC)Synovial Sarcomas+1 more Zelluna Immunotherapy AS 9
Early research (Phase 1)Not Yet RecruitingNCT06218940What this trial is testingHY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLCWho this might be right forNSCLC Stage IV Newsoara Biopharma Co., Ltd. 40
Not applicableAvailableNCT06761976What this trial is testingExpanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 MutationWho this might be right forAdvanced Non-small Cell Lung CancerCancer Bayer
Large-scale testing (Phase 3)Study completedNCT02044380What this trial is testingAfatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) MutationsWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 14
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816380What this trial is testingA Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Guangzhou JOYO Pharma Co., Ltd 216
Not applicableStudy completedNCT02596958What this trial is testingSafety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) ParticipantsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 996
Post-approval studies (Phase 4)Study completedNCT05219162What this trial is testingReal-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS).Who this might be right forAdvanced NSCLC AstraZeneca 182
Not applicableStudy completedNCT02285361What this trial is testingGIOTRIF rPMS in Korean Patients With NSCLCWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 1,272
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07287995What this trial is testingASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsWho this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 428
Early research (Phase 1)Looking for participantsNCT05098210What this trial is testingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more Fred Hutchinson Cancer Center 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07680790What this trial is testingStudy of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)Who this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 850
Testing effectiveness (Phase 2)Looking for participantsNCT06276283What this trial is testingDZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)Who this might be right forNon-small Cell Lung Cancer Dizal Pharmaceuticals 60
Testing effectiveness (Phase 2)Looking for participantsNCT05168566What this trial is testingStudy to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Teligene US 99
Early research (Phase 1)Looking for participantsNCT06461156What this trial is testingHS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)Who this might be right forLocally Advanced or Metastatic NSCLC Jiangsu Hansoh Pharmaceutical Co., Ltd. 230
Large-scale testing (Phase 3)Ended earlyNCT01244191What this trial is testingTivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerWho this might be right forNon Squamous, Non-small-cell Lung Cancer Daiichi Sankyo 1,048
Testing effectiveness (Phase 2)Looking for participantsNCT07232849What this trial is testingA Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT03233724What this trial is testingOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasWho this might be right forCarcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more National Cancer Institute (NCI) 9